Inhaled aerosolized iloprost in the evaluation of heart transplant candidates - Experiences with 45 cases

Journal of Clinical Anesthesia

Volumn 18, Issue 2, 2006, Pages 108-113

  Sablotzki, Armin ^a,d   Hentschel, Thomas ^b   Hofmann, Stefan ^a   Simm, Andreas ^a   Mühling, Jörg ^c   Czeslick, Elke ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Klinikum St Georg   (Germany)

Author keywords

Heart transplantation; Iloprost inhalation; Pulmonary hemodynamics

Indexed keywords

ILOPROST;

ABSENCE OF SIDE EFFECTS; ADULT; ARTERIAL PRESSURE; ARTICLE; BREATHING PATTERN; CLINICAL ARTICLE; CLINICAL TRIAL; FLUSHING; HEART DILATATION; HEART INDEX; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VENTRICLE PERFORMANCE; HUMAN; ISCHEMIC HEART DISEASE; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADULT; AGED; CARDIAC OUTPUT; FEMALE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; ILOPROST; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33645080926     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2005.08.018     Document Type: Article

References (21)

1. J.K. Kirklin, D.C. Naftel, and J.W. Kirklin Pulmonary vascular resistance and the risk of heart transplantation J Heart Transplant 7 1988 331 336
2. K.W. Erickson, M.R. Costanzo-Nordin, and E.J. O'Sullivan Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation J Heart Transplant 9 1990 526 537
3. S. Murali, B.F. Uretsky, and P.S. Reddy Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents Am Heart J 122 1991 1375 1381
4. N. Kieler-Jensen, I. Milocco, and S.E. Ricksten Pulmonary vasodilation after heart transplantation: a comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity J Heart Lung Transplant 12 1993 179 184
5. J. Pepke-Zabe, T.W. Higenbottam, and A. Dinh-Xuan Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension Lancet 338 1991 1173 1174
6. A. Haraldsson, N. Kieler-Jensen, and U. Nathorst-Westfelt Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance Chest 114 1998 780 786
7. L. Foubert, B. Fleming, and R. Latimer Safety guidelines for use of nitric oxide Lancet 339 1992 1615 1616
8. O.I. Miller Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide Lancet 346 1995 51 52
9. H. Olschewski, D. Walmrath, and R. Schermuly Aerosolized prostacyclin and iloprost in severe pulmonary hypertension Ann Intern Med 124 1996 820 824
10. M.M. Hoeper, H. Olschewski, and A. Ghofrani A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension J Am Coll Cardiol 35 2000 176 182
11. N. Kieler-Jensen, S.E. Ricksten, and O. Stenquist Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance J Heart Lung Transplant 13 1994 366 375
12. A. Sablotzki, E. Czeslick, and S. Schubert Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension Can J Anaesth 49 2002 1076 1080
13. C. Wiesenack, C. Fiegl, and A. Keyser Continuously assessed right ventricular end-diastolic volume as a marker of cardiac preload and fluid responsiveness in mechanically ventilated cardiac surgical patients Crit Care 9 2005 R226 R233
14. S.G. Sakka, A. Meier-Hellmann, and K. Reinhart Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution Intensive Care Med 26 2000 180 187
15. A. Sablotzki, E. Czeslick, and E. Gruenig First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance J Thorac Cardiovasc Surg 125 2003 960 962
16. T. Gessler, T. Schmehl, and M.M. Hoeper Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension Eur Respir J 17 2001 14 19
17. M.C. Rebsamen, D.J. Church, and D. Morabito Role of cAMP and calcium in endothelin-1-induced ANP release in rat cardiomyocytes Am J Physiol 273 1997 922 931
18. H. Kisch-Wedel, G. Kemming, and F. Meisner Prostaglandin I2-Derivate Iloprost (ILO) und Epoprostenol (PGI2) verbessern die linksventrikuläre Kontraktilität in vivo Anästh Intensivmed 42 2001 479 536
19. E.A. Bocchi, F. Bacal, and J.O. Auler Jr Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure Am J Cardiol 74 1994 70 72
20. F. Langer, O. Wendler, and W. Wilhelm Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analog Eur J Anaesthesiol 18 2001 770 773
21. E. Czeslick, T. Hentschel, and I. Friedrich Inhalative vasodilators in cardiosurgical intensive care medicine Z Herz Thorax Gefässchir 19 2005 132 145